Exchange: NYSEArca·Updated 06:04 PM EDT
XLV logo

XLV Health Care Select Sector SPDR Fund

$176.46
$0.48
(0.27%)
Today
Closed $176.71
$0.25
(0.14%)
After Hours
Vol8.55M
52W High$178.86
52W Low$141.39
63

Bullish Sentiment

How do you feel about XLV?

RenkoTradingSystem
$XLV & Health Care Sub-Industry Breakdown Health Care Sector (XLV): $177.19 (+1.86%), surging out of consolidation above rising moving averages. Medical Equipment ($DJUSAM): $2522.25 (+2.43%), breaking out above prior resistance with strong bullish acceleration. ⭐ Biotechnology ($DJUSBT) [Best]: $3898.31 (+1.75%), persistent high-tight trend breaking to new highs above $3819.21. ⭐ Health Care Providers ($DJUSHP) [Best]: $3150.96 (+2.09%), explosive vertical expansion clearing key resistance in a powerful V-recovery. Medical Supplies ($DJUSMS): $2042.70 (+2.27%), steady uptrend continuation clearing $2001.17 resistance. Pharmaceuticals ($DJUSPR): $1289.11 (+1.47%), bouncing strongly off $1217.54 support back into its broad range. $SPY
1
RenkoTradingSystem
$XLV (Weekly & 195-Min Renko) System Status: GO (2nd Green Brick Confirmed) Setup Trigger (195-Min 1% Renko) • 2nd Green Brick Confirmed: Printed at $170.00 off 20-EMA/PSAR support ($165.49–$166.16) • StochRSI: Rebounding out of oversold zone (0.306) • Extension: Low at 2.31% above 20-EMA ($166.16) Higher-Timeframe Support (Weekly) • Weekly RSI(14): 61.68 (Healthy trend expansion) • Weekly Renko: Rebounded off $165.87 to print Green Brick ($169.29) above 20-EMA ($162.72) The Takeaway: System buy signal is LIVE with 2nd green brick confirmed at $170.00. Risk is clearly defined below PSAR ($165.49) & 20-EMA ($166.16). Execution Checklist • Entry: Buy zone ~$170.00 • Hard Stop Loss: $165.40 • Invalidation: Close if 195-min red brick prints below $165.49 $SPY $QQQ
1
1
RenkoTradingSystem
Correction: Perfect Pullback Structure: The weekly Renko chart shows a shallow, orderly "4-brick" red pullback that successfully held support above a rising EMA(20) at 162.72. Should read "3-brick" $XLV $SPY $QQQ $IWM $DIA
1
1
howardlindzon
defense is winning … che k out $XLV and its components they get all the ai benefits and so maybe it could work beyond defense ?
2
ElliottwaveForecast
$XLV — Blue Box Support Coming Into Focus XLV was pulling back in an A-B-C correction and approaching the 167.09–162.48 Blue Box. 📌 The setup: with the larger trend still on the Right Side higher, we were looking for buyers to appear inside this high-frequency area and potentially complete the correction. 👀 The key was simple: let price reach the zone first, then watch for a bullish reaction. #XLV #Healthcare #BlueBox #ElliottWave #Trading
1
seeitmarket
$XLV Health Care Sector ETF marching higher... but look at those candle sticks. It's been a volatile rally! #IBDPartner
1
ElliottwaveForecast
$XLV — Bulls Remain in Control After the Sharp Reversal Group 3 Weekend Update: XLV is Turning Up above the 165.20 invalidation level. The rally from the ((b)) low is developing impulsively, with wave (i) still expected to complete slightly higher. 🎯 Expected path: one more push toward 171.3–171.5 to complete wave (i) → corrective wave (ii) toward the 169.5 area → then another bullish leg toward 172+. #XLV #Healthcare #ElliottWave #Stocks #Trading
1
GettnFibbywIT
$XLV $SPY Healthcare Sector - (XLV) / Weekly Chart Price probed and retested the $157 - $160 ish level from 6/29 to 7/20 where buyers came in below. Weekly prices during that period closed above the $160 level - Holding an area of prior 2/23/26 and 9/3/24 resistance. From 7/27 to 8/3, price probed back down to the $160 area but with price AGAIN closing above. Currently, both absolute and trend momentum remain in a bullish regime. For those techncial traders who employ structured credit spread strategies (not a recommendtion to buy/sell), but the $157 - $160 level appears to be an area of defined market market memory and that price has accepted. GL
1
SignalYieldAI
$XLV — Health Care is the quiet leader. All three layers agree. Institutional flow: HC is the top inflow sector at +$0.05B (institutional +$0.03B, retail +$0.02B). Tech is at −$0.03B outflow. Momentum: HC is up across every period — +5.31% 1W, +5.61% 1M, +9.99% 3M, +20.88% 6M. Cleanest trend in the sector table. Price: XLV at $177.15 — all-time high. Recovered from every crisis: 2008 −39.7%, 2020 −28.3% (120-day recovery). Currently +14.1% in the easing cycle — the only sector with clean positive performance during cuts. Top holdings: LLY 15.1%, JNJ 10.4%, ABBV 7.5%, MRK 5.9%, UNH 5.4%. Other sectors don't align. Tech has institutional outflow but +24.45% over 6M. Materials leads 13F (+14.77%) but flat momentum. Financials weak across the board. HC is the only one where the layers match. NFA.
ElliottwaveForecast
$XLV should continue rally against April-2026 low from the #bluebox area. It was earlier expected 3 swing pullback into 167.09 - 162.48 area from early September-2026 view. Buyers expected to enter there for next rally. It ended at 165.11 low & broke to new high, targeting 179.35 - 183.75 before short term pullback may start. #Elliottwave
EWF_Sandile
$XLV – 09.08.2026 Chart forecast anticipated a bullish move from the 167.09 – 162.48 zone, and as expected, buyers stepped in. Long positions secured partial profits, with the remaining exposure now running risk‑free. Trade the Blue box. High frequency areas. #trading #Elliottwave
TradeWithInsight
$XLV Health care finished up 2.5% today while tech $XLK finished down 3.0%. That's a 5.5-point gap between two sectors in one session, and since October 2020 health care has beaten tech by that much on only 4 other days. PPI and retail sales come out at 8:30 AM ET tomorrow, with $TSM reporting before the bell.
kevinbtravers
$XLV Investors paid up for earnings visibility and AI infrastructure while dumping rate-sensitive and commodity-linked groups. Why the beat was not what the market cared about, and the number that decides what comes next: https://thedailyrip.stocktwits.com/p/father-time-always-wins-buffett-hands-off-berkshire-s-chair?utm_source=stocktwits&utm_medium=organic_social&utm_campaign=daily_rip&utm_content=xlv_sector-rotation-watch
DidYouReadThis
If you’ve seen a drug with FDA approval wait at least 54 days to give a final price per dose, was it actually? $XLV $IBB $OTLK $VOO

Advertisement|Remove ads.